Showing results (191-200 of 204) with videos related to

Sort By:
Pageof 21
Nature Materials|June 22, 2010
Nanogel antigenic protein-delivery system for adjuvant-free intranasal vaccinesTomonori Nochi, Yoshikazu Yuki, Haruko Takahashi, et al.
Scientific Reports|February 5, 2021
Pruritus is common in patients with chronic liver disease and is improved by nalfurafine hydrochlorideShuhei Yoshikawa, Takeharu Asano, Mina Morino, et al.
The Tohoku Journal of Experimental Medicine|January 24, 2024
Treatment of ZC4H2 Variant-Associated Spastic Paraplegia with Selective Dorsal Rhizotomy and Intensive Postoperative Rehabilitation: A Case ReportToshiki Inotani, Akira Horaguchi, Yuko Morishita, et al.
Internal Medicine (Tokyo, Japan)|January 11, 2019
A Diagnostically Challenging Case of Autoimmune Pancreatitis Due to Contamination of the Pathological Specimen with Early Gastric CancerMina Morino, Masanari Sekine, Keita Matsumoto, et al.
Breast Cancer (Tokyo, Japan)|June 28, 2018
The efficacy and feasibility of dose-dense sequential chemotherapy for Japanese patients with breast cancerDaisuke Takabatake, Yukiko Kajiwara, Shoichiro Ohtani, et al.
International Journal of Molecular Sciences|December 10, 2021
YES1 as a Therapeutic Target for HER2-Positive Breast Cancer after Trastuzumab and Trastuzumab-Emtansine (T-DM1) Resistance DevelopmentMiwa Fujihara, Tadahiko Shien, Kazuhiko Shien, et al.
The Journal of Clinical Investigation|August 9, 2013
Rice-based oral antibody fragment prophylaxis and therapy against rotavirus infectionDaisuke Tokuhara, Beatriz Álvarez, Mio Mejima, et al.
Breast Cancer Research and Treatment|September 13, 2017
Durable complete response in HER2-positive breast cancer: a multicenter retrospective analysisNaoki Niikura, Akihiko Shimomura, Yumi Fukatsu, et al.
Breast Cancer Research and Treatment|September 9, 2023
Prognostic impact of adjuvant endocrine therapy for estrogen receptor-positive and HER2-negative T1a/bN0M0 breast cancerShinsuke Sasada, Naoto Kondo, Hiroya Hashimoto, et al.
Plant Biotechnology Journal|April 23, 2013
Induction of toxin-specific neutralizing immunity by molecularly uniform rice-based oral cholera toxin B subunit vaccine without plant-associated sugar modificationYoshikazu Yuki, Mio Mejima, Shiho Kurokawa, et al.
Pageof 21